Cartesian Therapeutics, Inc. — Form D

Cartesian Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-17. The offering totals $26.0M, of which $3.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (88)

Showing 25 of 88 people.

NameRoleLocation
Cole DouglasDirectorWatertown, MA
Robert Barton LangerDirectorWatertown, MA
George Barton SiberDirectorWatertown, MA
Yuriy Barton UdaltsovDirectorWatertown, MA
David Barton SiewersExecutive OfficerWatertown, MA
CARL GORDONDirectorSAN DIEGO, CA
Werner CautreelsDirectorWaltham, MA
Werner CautreelsExecutive OfficerWaltham, MA
Timothy A SpringerDirectorWatertown, MA
Chris A JewellExecutive OfficerGaithersburg, MD
Michael C SingerDirectorGaithersburg, MD
Kemal C MalikDirectorGaithersburg, MD
Carsten BrunnDirectorGaithersburg, MD
Carsten BrunnExecutive OfficerGaithersburg, MD
Metin A KurtogluExecutive OfficerGaithersburg, MD
Timothy C BarabeDirectorGaithersburg, MD
Nishan C de SilvaDirectorGaithersburg, MD
Patrick A ZennerDirectorGaithersburg, MD
Emily A EnglishExecutive OfficerGaithersburg, MD
Carrie S CoxDirectorGaithersburg, MD
Blaine DavisExecutive OfficerGaithersburg, MD
Murat C KalayogluDirectorGaithersburg, MD
Milos A MiljkovicExecutive OfficerGaithersburg, MD
Metin S KurtogluExecutive OfficerGaithersburg, MD
Aymeric S SallinDirectorGaithersburg, MD

Other filings by this issuer (15)

FiledFormOfferingSold
2024-07-17D$130.0M$130.0M
2023-12-04D/A$60.3M$60.3M
2023-12-01D$60.3M$60.3M
2020-08-18D$25.0M$25.0M
2020-01-02D$70.0M$70.0M
2019-09-04D$5.8M$5.8M
2017-07-11D$50.0M$50.0M
2016-12-14D$5.0M$5.0M
2015-09-10D$40.6M$37.4M
2015-04-23D$7.5M$5.9M
2014-08-28D$4.5M$4.5M
2014-07-15D$6.0M$6.0M
2014-04-09D$10.0M$5.3M
2011-11-17D$22.0M$22.0M
2010-04-06D$15.0M$15.0M

More